Menu
Menu
Menu
| S. No | Product Name | DMF | WHO-GMP |
|---|---|---|---|
COMMERCIALLY MANUFACTURING PRODUCTS | |||
| 1 | Domperidone IP/ BP/ Ph. Eur | DMF Available | Available |
| 2 | Desloratadine BP/Ph.Eur/USP | DMF Available | Available |
| 3 | Domperidone Maleate IP/ BP/ Ph. Eur | DMF Available | Available |
| 4 | Esomeprazole Magnesium Tri-Hydrate IP/ Ph. Eur./BP | DMF Available | Available |
| 5 | Favipiravir In-House / IP | DMF Available | Available |
| 6 | Hydroxychloroquine Sulphate IP/Ph. Eur/USP | DMF Available | Available |
| 7 | Loratadine BP/ Ph. Eur /USP | DMF Available | Available |
| 8 | Losartan Potassium IP/BP/ Ph. Eur /USP | DMF Available | Available |
| 9 | Molnupiravir In-House | DMF Available | Available |
| 10 | Omeprazole IP/ BP/ USP/ Ph. Eur | DMF Available | Available |
| 11 | Pantoprazole Sodium Sesquihydrate IP/ Ph. Eur /USP/BP | DMF Available | Available |
| 12 | Terbinafine Hydrochloride IP/ BP/ USP/ Ph. Eur. | DMF Available | Available |
| 13 | Alpha Lipoic acid/Thioctic acid Ph. Eur/ USP/BP | Tech pack Available | Available |
| 14 | Bempedoic acid In-House | Tech pack Available | Available |
| 15 | Cyproheptadine HCl IP/BP/ Ph. Eur /USP | Tech pack Available | Available |
| 16 | Dapagliflozin | Tech pack Available | Available |
| 17 | Dexlansoprazole | Tech pack Available | Available |
| 18 | Empagliflozin | Tech pack Available | Available |
| 19 | Fexofenadine Hydrochloride IP/USP/Ph. Eur/BP | Tech pack Available | Available |
| 20 | Imatinib Mesylate IP/Ph. Eur | Tech pack Available | Available |
| 21 | Itraconazole | Tech pack Available | Available |
| 22 | Lapatanib In-House | Tech pack Available | Available |
| 23 | Levocetrizine | Tech pack Available | Available |
| 24 | Loperamide Hydrochloride IP/BP/ Ph. Eur /USP | Tech pack Available | Available |
| 25 | Rupatadine Fumarate IP | Tech pack Available | Available |
| 26 | Vildagliptin IP/In-House | Tech pack Available | Available |
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
| S. No | Product Name | DMF | WHO-GMP |
|---|---|---|---|
PRODUCTS UNDER VALIDATION | |||
| 1 | Telmisartan | Available | |
| 2 | Fluconazole |
| S. No. | Product Name | DMF | WHO-GMP |
|---|---|---|---|
PRODUCTS UNDER VALIDATION | |||
| 1 | Alpha Lipoic Acid/Thioctic Acid | ||
| 2 | Vildagliptin | ||
| 3 | Telmisartan | Available | |
| 4 | Fluconazole | ||
| 5 | Fexofenadine Hydrochloride | ||
| 6 | Dexlansoprazole |
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
| S. No. | Product Name | DMF | WHO-GMP |
|---|---|---|---|
PRODUCTS UNDER DEVELOPMENT | |||
| 1 | Ticagrelor | ||
| 2 | Sitagliptin Phosphate | ||
| 3 | Fenofibrate | ||
| 4 | Escitalopram | ||
| 5 | Irbesartan | ||
| 6 | Bilastine | ||
| 7 | Dapagliflozin | ||
| 8 | Ivabradine HCl | ||
| 9 | Tolvaptan | ||
| 10 | Dabigatran | ||
| 11 | Tofacitinib Citrate | ||
| 12 | Rosuvastatin Calcium | ||
| 13 | Empagliflozin | ||
| 14 | Canagliflozin | ||
| 15 | Etoricoxib | ||
| 16 | Minoxidil | ||
| 17 | Cyclobenzaprine Hydrochloride | ||
| 18 | Tapentadol Hydrochloride | ||
| 19 | Linezolid | ||
| 20 | Drotaverine | ||
| 21 | Mefenamic Acid |
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
© 2022 TAGOOR LABORATORIES PVT. LTD. All Rights Reserved.
English
Arabic
Bengali
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Korean
Portuguese
Russian
Spanish
Turkish
Vietnamese